Which of the following statements regarding administration of varicella-zoster vaccine to patients >60 years old is true?
ExplanationThe correct statement regarding the administration of varicella-zoster vaccine to patients >60 years old is: C. It will decrease the risk of developing post-herpetic neuralgia. The varicella-zoster vaccine is a live attenuated vaccine that provides protection against both varicella (chickenpox) and herpes zoster (shingles). While the vaccine is generally recommended for individuals 60 years and older, there are some specific considerations. Option A is incorrect. The varicella-zoster vaccine is a live vaccine and is generally not recommended for immunocompromised patients. Option B is incorrect. The vaccine is recommended for patients in the age group of >60 years. Option D is incorrect. The varicella-zoster vaccine has been shown to decrease the risk of developing shingles in individuals 60 years and older. It is not 100% effective but can reduce the incidence and severity of shingles.
